Objective To study and analyze the effect of methylprednisolone combined with azithromycin in the treatment of mycoplasma pneumoniae lobar pneumonia in children. Methods The study period was from June 2021 to June 2022. During this period, 80 children with Mycoplasma pneumoniae lobule pneumonia admitted to our hospital were randomly divided into experimental group and control group by randomized controlled trial, with 40 cases in each group. The control group was treated with azithromycin only, while the experimental group was treated with methylprednisolone and azithromycin combined. The clinical therapeutic effect, clinical indicators and the degree of pain before and after treatment were evaluated. Results After treatment, the total effective rate of the experimental group was 97.50％, which was significantly higher than that of the control group, the difference was statistically significant (P＜0.05). The experimental group of children with cough relief, fever, lung rales disappeared, hospitalization time were shorter than the control group, the difference was statistically significant (P＜0.05). Before treatment, there was no significant difference in visual analog scores between the experimental group and the control group (P＞0.05). After treatment, the visual analog score of the experimental group was significantly lower than that of the control group, and the difference was statistically significant (P＜0.05). Conclusion The combination of methylprednisolone and azithromycin in the treatment of mycoplasma pneumoniae lobar pneumonia in children can effectively promote the recovery of children, improve the clinical indicators of children, and reduce the sense of pain in children.
mycoplasma pneumoniae lobar pneumonia in childrenMethylprednisoloneAzithromycin
万方数据
